- Home
- ALZN vs MSPR Comparison
ALZN vs MSPR Comparison
Compare ALZN & MSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- MSPR
- Stock Information
- Founded
- ALZN 2016
- MSPR 2014
- Country
- ALZN United States
- MSPR United States
- Employees
- ALZN N/A
- MSPR N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- MSPR
- Sector
- ALZN Health Care
- MSPR
- Exchange
- ALZN Nasdaq
- MSPR NYSE
- Market Cap
- ALZN 6.1M
- MSPR 4.9M
- IPO Year
- ALZN 2021
- MSPR N/A
- Fundamental
- Price
- ALZN $1.17
- MSPR $2.01
- Analyst Decision
- ALZN Strong Buy
- MSPR
- Analyst Count
- ALZN 1
- MSPR 0
- Target Price
- ALZN $32.00
- MSPR N/A
- AVG Volume (30 Days)
- ALZN 145.7K
- MSPR 132.4K
- Earning Date
- ALZN 12-12-2024
- MSPR 11-14-2024
- Dividend Yield
- ALZN N/A
- MSPR N/A
- EPS Growth
- ALZN N/A
- MSPR N/A
- EPS
- ALZN N/A
- MSPR N/A
- Revenue
- ALZN N/A
- MSPR $10,734,000.00
- Revenue This Year
- ALZN N/A
- MSPR $293,208.70
- Revenue Next Year
- ALZN N/A
- MSPR N/A
- P/E Ratio
- ALZN N/A
- MSPR N/A
- Revenue Growth
- ALZN N/A
- MSPR 217.86
- 52 Week Low
- ALZN $1.06
- MSPR $1.43
- 52 Week High
- ALZN $15.06
- MSPR $66.00
- Technical
- Relative Strength Index (RSI)
- ALZN 45.87
- MSPR N/A
- Support Level
- ALZN $1.13
- MSPR N/A
- Resistance Level
- ALZN $1.23
- MSPR N/A
- Average True Range (ATR)
- ALZN 0.06
- MSPR 0.00
- MACD
- ALZN 0.01
- MSPR 0.00
- Stochastic Oscillator
- ALZN 37.20
- MSPR 0.00
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.